$PFE
2 long-form articles and 2 pre-market mentions covering $PFE from AskMelon Research.
Pfizer's 6% dividend leans on a $43B oncology bet and a GAAP payout near 130%
Pfizer just printed a clean beat — $14.45 billion in Q1 2026 revenue, up 5.4%, an adjusted EPS of $0.75 that topped consensus, and management reaffirming full-year guidance of $59.5–62.5 billion. Read…
AstraZeneca's 16% oncology engine is real — its 28% GAAP margin and a Beijing courtroom are the tax nobody prices
AstraZeneca closed Q1 2026 with $15.29 billion in revenue, up 8% at constant currency and 13% as reported, with an oncology franchise that grew 16% to $6.8 billion and now supplies 44% of the top line…
Friday, August 7, 2026
July Nonfarm Payrolls at 8:30 AM is the session's single pivot: a soft +73K print (vs ~80K consensus, unemployment holding 4.2%) with a combined ~258K in downward May–June revisions lands directly aga…
Thursday, August 6, 2026
The SPCX lockup — 911.5 million insider shares eligible at today's open — is the session's defining structural event, landing against a stock that closed 13.6% lower Wednesday and sits 20% below its $…